Q/C Technologies, Inc. Accrued Liabilities, Current
Q/C Technologies, Inc. (QCLS) had Accrued Liabilities, Current of $764.89 thousand as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2026-08-12
- 2026-06-30: Accrued Liabilities, Current $764.89K.
- 2026-03-31: Accrued Liabilities, Current $422.69K.
- 2025-12-31: Accrued Liabilities, Current $372.99K; Accrued Liabilities, Current as first filed $382.99K.
- 2025-03-31: Accrued Liabilities, Current $428.66K.
| Period end | Accrued Liabilities, Current | Accrued Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $764.89K 10-Q · filed 2026-08-12 | |
| 2026-03-31 | $422.69K 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $372.99K 10-Q · filed 2026-08-12 | $382.99K 10-K · filed 2026-04-15 |
| 2025-03-31 | $428.66K 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $386.68K 10-K · filed 2026-04-15 | |
| 2024-09-30 | $455.21K 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $524.36K 10-Q · filed 2024-08-19 | |
| 2024-03-31 | $511.05K 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $637.14K 10-K · filed 2025-04-11 | |
| 2023-09-30 | $685.94K 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $497.45K 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $169.94K 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $316.67K 10-K · filed 2024-04-01 | |
| 2022-09-30 | $324.63K 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $223.43K 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $422.02K 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $119.11K 10-K · filed 2023-03-31 | |
| 2021-09-30 | $138.87K 10-Q/A · filed 2021-11-15 | |
| 2020-12-31 | $205.31K 10-Q/A · filed 2021-11-15 | $123.61K 10-K · filed 2021-03-01 |
| 2020-09-30 | $237.46K 10-Q · filed 2020-11-16 | |
| 2020-06-30 | $789.09K 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $1.13M 10-Q · filed 2020-05-15 | |
| 2019-12-31 | $232.83K 10-K · filed 2021-03-01 | $812.72K 10-K · filed 2020-03-25 |
| 2019-09-30 | $808.16K 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $816.09K 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $869.14K 10-Q · filed 2019-05-20 | |
| 2018-12-31 | $1.23M 10-K · filed 2020-03-25 | |
| 2018-09-30 | $1.51M 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $751.02K 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $702.42K 10-Q · filed 2018-07-13 | |
| 2017-12-31 | $736.51K 10-K · filed 2019-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |